Mindpeak News: Developments & Achievements

Mindpeak announces its collaboration with Sagis Dx to conduct a spearheading study, assessing the efficacy of the new Mindpeak Onychomycosis AI algorithm.

Read more ⟶

October 18, 2024

Mindpeak’s PD-L1 CPS AI to identify more patients for checkpoint therapy in gastric cancer at pathologist-level interobserver concordance

Read more ⟶

Find out more about our AI-based diagnostics

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Mindpeak Breast IHC being displayed on a monitor

About Mindpeak

We build automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Our tools assist cancer experts in providing reliable and reproducible diagnoses.
‍
This frees specialists from tedious, repetitive tasks such as quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. Explainable AI (xAI) results provide the required trust of pathologists into our tools.

Contact us

Mindpeak GmbH
Zirkusweg 2
20359 Hamburg
Germany
Email: info@mindpeak.ai
Telephone: +49 40 35 67 67 97

Regulatory Note:
Unless otherwise stated all products are intended for Research Use Only, not for use in diagnostic procedures.

Supported by:

Terms & Conditions

Contact

Felix Faber, Founder and CEO of Mindpeak GmbH, announced as Innovator of the Month

Find out more about our AI-based diagnostics

About Mindpeak

Company information

Contact us